Medicine
Draximage Dtpa 20 mg powder for injection
Draximage Dtpa 20 mg powder for injection is a prescription medicine containing Pentetic acid for inhalation, intravenous use, marketed by Jubilant Radiopharma, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store the unreconstituted reaction vials at 25 °C (77 °F), excursions…
Key facts
- Active ingredient (INN)
- Pentetic acid
- Brand
- Draximage Dtpa
- Strength
- 20 mg
- Dosage form
- Powder for injection
- Route
- Inhalation, intravenous
- Packs
- 30 injection
- Marketing authorisation holder
- Jubilant Radiopharma
- Manufacturer
- Jubilant RadiopharmaIndia
- Origin register
- US FDA, United States
- Storage
- Store the unreconstituted reaction vials at 25 °C (77 °F), excursions permitted between 15 °C and 30 °C (59 °F and 86 °F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 29 December 1989
- Identifiers
- DailyMed set ID becdab53-f7a7-7280-6930-21f3a61b99e7NDC 65174-288Application NDA018511
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 injection, powder, lyophilized, for solution in 1 kit | 65174-288-30 | Jubilant RadiopharmaIndia | 29 December 1989 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Pentetic acid
Clinical summary
Pentetic acid is a lead chelator indicated for DRAXIMAGE ® DTPA is a kit for the preparation of Technetium Tc 99m pentetate injection, among other approved uses. MedsAcross supplies Pentetic acid for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Pentetic acidFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- DRAXIMAGE DTPA prescribing information (Jubilant Radiopharma) · U.S. National Library of Medicine, DailyMed
Need Draximage Dtpa 20 mg powder for injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.